Updates in Head and Neck Cancer Treatment: Integrating Checkpo…

CME

Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

July 30, 2021

Host: Ezra Cohen, MD

Guest: Barbara Burtness, MD

Head and neck squamous cell carcinomas (HNSCC) represent a significant healthcare burden due to associated morbidity and mortality. Most patients survive less than a year after diagnosis and report a

Download Episode

Gain access to Blubrry tools that help build your podcast, including free podcast stats!

CME

Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

Services